First Oral Drug for Moderate-To-Severe Ulcerative Colitis

被引：0
|
作者：
Aschenbrenner, Diane S.
机构：
来源：
AMERICAN JOURNAL OF NURSING | 2018年 / 118卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R47 [护理学];
学科分类号：
1011 ;
摘要：
Immediate-release tofacitinib (Xeljanz) is now approved to treat moderate-to-severe ulcerative colitis. Nurses should assess patients for infections prior to the initiation of and throughout tofacitinib treatment.
引用
收藏
页码：22 / 22
页数：1
相关论文
共 50 条
  • [1] First oral drug for moderate-to-severe ulcerative colitis (vol 118, pg 22, 2018)
    Aschenbrenner, D. S.
    AMERICAN JOURNAL OF NURSING, 2019, 119 (09) : 10 - 10
  • [2] Etrolizumab in moderate-to-severe ulcerative colitis
    Armuzzi, Alessandro
    Felice, Carla
    LANCET, 2014, 384 (9940): : 285 - 286
  • [3] An evaluation of risankizumab for the treatment of moderate-to-severe ulcerative colitis
    Johnson, Amanda M.
    Loftus Jr, Edward V.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2024, 24 (12) : 1317 - 1327
  • [4] Spotlight: Pharmacological Management of Moderate-to-Severe Ulcerative Colitis
    Singh, Siddharth
    Loftus Jr, Edward V.
    Limketkai, Berkeley N.
    Haydek, John P.
    Agrawalm, Manasi
    Scott, Frank I.
    Ananthakrishnan, Ashwin N.
    GASTROENTEROLOGY, 2024, 167 (07) : 1344 - 1344
  • [5] Safety evaluation of ustekinumab for moderate-to-severe ulcerative colitis
    Miyoshi, Jun
    Matsuura, Minoru
    Hisamatsu, Tadakazu
    EXPERT OPINION ON DRUG SAFETY, 2022, 21 (01) : 1 - 8
  • [6] Vedolizumab versus adalimumab for moderate-to-severe ulcerative colitis
    Tribich, Samuel
    Maurice, James
    FRONTLINE GASTROENTEROLOGY, 2020, 11 (02) : 173 - 173
  • [7] Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis
    Biemans, Vince B. C.
    Hoentjen, Frank
    Pierik, Marieke J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (01): : 92 - 92
  • [8] Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis
    Sands, Bruce E.
    Peyrin-Biroulet, Laurent
    Loftus, Edward V., Jr.
    Danese, Silvio
    Colombel, Jean-Frederic
    Toruner, Murat
    Jonaitis, Laimas
    Abhyankar, Brihad
    Chen, Jingjing
    Rogers, Raquel
    Lirio, Richard A.
    Bornstein, Jeffrey D.
    Schreiber, Stefan
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (13): : 1215 - 1226
  • [9] Pharmacokinetics of golimumab in patients with moderate-to-severe ulcerative colitis
    Berends, S.
    Strik, A.
    van Egmond, P.
    Brandse, H.
    Mathot, R.
    D'Haens, G.
    Lowenberg, M.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S424 - S424
  • [10] Medical therapy versus surgery in moderate-to-severe ulcerative colitis
    Fiorino, Gionata
    Danese, Silvio
    Giacobazzi, Giovanni
    Spinelli, Antonino
    DIGESTIVE AND LIVER DISEASE, 2021, 53 (04) : 403 - 408
12345